Cargando…
Choroidal thickening with serous retinal detachment in BRAF/MEK inhibitor-induced uveitis: A case report
BACKGROUND: Immune checkpoint inhibitors have revolutionized the treatment of patients with unresectable metastatic malignant melanoma. In addition to systemic side effects, several usually mild ocular adverse effects have been reported. We report a case of rarely reported vision-threatening bilater...
Autores principales: | Kiraly, Peter, Groznik, Alenka Lavrič, Valentinčič, Nataša Vidovič, Mekjavić, Polona Jaki, Urbančič, Mojca, Ocvirk, Janja, Mesti, Tanja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294905/ https://www.ncbi.nlm.nih.gov/pubmed/35979276 http://dx.doi.org/10.12998/wjcc.v10.i19.6536 |
Ejemplares similares
-
Ocular Changes in Metastatic Melanoma Patients Treated with MEK Inhibitor Cobimetinib and BRAF Inhibitor Vemurafenib
por: Gavric, Ana Ursula, et al.
Publicado: (2018) -
Various Clinical Presentations of Uveitis Associated with Durvalumab Treatment
por: Vrabic, Nika, et al.
Publicado: (2022) -
The Comparison of Retinal Microvascular Findings in Acute COVID-19 and 1-Year after Hospital Discharge Assessed with Multimodal Imaging—A Prospective Longitudinal Cohort Study
por: Jevnikar, Kristina, et al.
Publicado: (2023) -
The impact of acute COVID-19 on the retinal microvasculature assessed with multimodal imaging
por: Jevnikar, Kristina, et al.
Publicado: (2022) -
The Role of ACE, ACE2, and AGTR2 Polymorphisms in COVID-19 Severity and the Presence of COVID-19-Related Retinopathy
por: Jevnikar, Kristina, et al.
Publicado: (2022)